Cleared Traditional

K240605 - Ultra RapidWarm Blast

K240605 is the FDA 510(k) clearance for Ultra RapidWarm Blast by Vitrolife Sweden AB. It is a Class 2 Obstetrics & Gynecology device (product code MQL) cleared through the Traditional 510(k) pathway after a 156-day FDA review.

K240605 · Vitrolife Sweden AB · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2024
Decision
156d
Days
Class 2
Risk

K240605 is an FDA 510(k) clearance for the Ultra RapidWarm™ Blast. Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Vitrolife Sweden AB (Västra Frölunda, SE). The FDA issued a Cleared decision on August 7, 2024 after a review of 156 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Vitrolife Sweden AB devices

Submission Details

510(k) Number K240605 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 2024
Decision Date August 07, 2024
Days to Decision 156 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d faster than avg
Panel avg: 160d · This submission: 156d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 121
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K240605.
Giftlife® Single-Step Medium Plus
K242968 · Gimbo Medical Technology Shenzhen Co., Ltd. · Nov 2024
V-VITFREEZE and V-VITWARM
K240176 · Vitromed GmbH · Sep 2024
Vitrification Solution Set and Warming Solution Set
K233846 · Ecmpc, LLC · Aug 2024
Cryo-straw (Type I, Type III)
K233477 · Shandong Wego Ruisheng Medical Device Co., Ltd. · Jul 2024
Giftlife™ Fertilization Medium
K240149 · Gimbo Medical Technology Shenzhen Co., Ltd. · Jun 2024
Oocyte Flushing & Retrieval Medium
K234023 · Gimbo Medical Technology Shenzhen Co., Ltd. · May 2024